October 13th 2025
Patients with proliferative diabetic retinopathy, central retinal vein occlusion and branch retinal vein occlusion experienced fluctuating retinal perfusion, investigators reported
September 24th 2025
RPE mosaic imaged for the first time in a living retina
March 4th 2009The retinal pigment epithelial (RPE) cell mosaic has been imaged for the first time in a living retina using an adaptive optics scanning laser ophthalmoscope (AOSLO), according to a report published in the March issue of Investigative Ophthalmology & Visual Science.
Single Use Instrument recommendations set to stimulate reform in decontamination procedures?
March 4th 2009The recommendations for 'the use of single use instruments where possible' when performing 'high-risk' surgical procedures, has not only led to a growth in the single use market segment, but has stimulated massive reform in decontamination procedures, creating increased demand globally for reusable instruments due to new processes and longer lead times.
VEGF Trap-Eye active against DME
February 4th 2009A single intravitreal injection of 4.0 mg vascular endothelial growth factor (VEGF) Trap-Eye is associated with bioactivity against diabetic macular oedema (DME), according to study results published in the January issue of the British Journal of Ophthalmology.
ROP drug granted orphan designation
January 28th 2009Iplex (mecasermin rinfabate), a complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its predominant binding protein IGFBP-3 (rhIGFBP-3) developed for the treatment of retinopathy of prematurity (ROP), has been granted orphan drug designation by the EMEA, according to a statement from Iplex developers Insmed Inc and Premacure AB.